Regional meeting on antimicrobial resistance, 10-13 November 2014
Antimicrobial resistance (AMR) is a growing global public health threat with serious health, political and economic implications. It threatens the effective treatment of an ever-increasing range of infections caused by microbes as well as the achievements made by the modern medicine, including the use of antibiotics in recent past. The Regional Office for South-East Asia has developed a simple and practical Regional Strategy on Prevention and Containment of AMR in 2010. The Sixty-third Regional Committee adopted a resolution (RC/63/R4) on prevention and containment of AMR and endorsed the Regional Strategy on AMR. The Health Ministers of the SEA Region in 2011 gave a call to comprehensively address this issue through Jaipur Declaration on AMR. Through its World Health Assembly resolution, the Assembly urged WHO to develop a global action plan against AMR and submit to WHA in 2015.
Antimicrobial Resistance - Global Report on Surveillance 2014
WHO's first global report on antimicrobial resistance, with a focus on antibiotic resistance, reveals that it is no longer a prediction for the future. Antibiotic resistance when bacteria change and antibiotics fail - is happening right now, across the world.
Jaipur Declaration on Antimicrobial Resistance
Acknowledging the growing global importance of antimicrobial resistance, the Health Ministers of all Member States of the WHO South-East Asia Region adopted the “Jaipur Declaration on Antimicrobial Resistance”. The Declaration recognizes that it is imperative that the national governments accord utmost priority to this problem to preserve the efficacy of antibiotics in the fight against microbial diseases.
SEA Regional Strategy on Antimicrobial Resistance
A Regional Strategy for Prevention and Containment of Antimicrobial Resistance has been finalized by a group of experts who also gave a call to Member countries to adapt this strategy and rapidly scale-up the interventions detailed in it. The goal of the strategy is to reduce mortality and morbidity due to resistant organisms and to preserve efficacy of available antimicrobial agents as well as discovery of new drugs/interventions.
AMR Meeting Reports
Lab based surveillance of AMR
Presentation on Antimicrobial resistance
Regional Strategy on AMR
Monitoring drug resistance in influenza viruses
Report of Regional meeting on AMR
HIV drug resistance monitoring, 2006
Role of education in rational use of medicines
- Prevention and Control of Hospital Associated Infections